APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK Cells

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global NK Cells Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchNK Cells Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cells Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NK Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cells Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cells Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global NK Cells market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for NK Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for NK Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for NK Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for NK Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of NK Cells include Affimed NV, Altor BioScience, Chipscreen Biosciences, Fortress Biotech, Henry Ford Health Services, Innate Pharma, NantKwest, NKT and Sorrento Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for NK Cells, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of NK Cells, also provides the sales of main regions and countries. Of the upcoming market potential for NK Cells, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NK Cells sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global NK Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for NK Cells sales, projected growth trends, production technology, application and end-user industry.

NK Cells Segment by Company

Affimed NV

Altor BioScience

Chipscreen Biosciences

Fortress Biotech

Henry Ford Health Services

Innate Pharma

NantKwest

NKT

Sorrento Therapeutics

Bristol-Myers Squibb

Takeda

NK Cells Segment by Type

Mogamulizumab

Lorvotuzumab Mertansine

Others

NK Cells Segment by Application

Cancer

Cardiovascular Diseases

Others

NK Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of NK Cells in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NK Cells sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NK Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Mogamulizumab Major Manufacturers Table 3. Lorvotuzumab Mertansine Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global NK Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cancer Major Manufacturers Table 7. Cardiovascular Diseases Major Manufacturers Table 8. Others Major Manufacturers Table 9. NK Cells Industry Trends Table 10. NK Cells Industry Drivers Table 11. NK Cells Industry Opportunities and Challenges Table 12. NK Cells Industry Restraints Table 13. Global NK Cells Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global NK Cells Revenue by Region (2021-2026) & (US$ Million) Table 15. Global NK Cells Revenue by Region (2027-2032) & (US$ Million) Table 16. Global NK Cells Revenue Market Share by Region (2021-2026) Table 17. Global NK Cells Revenue Market Share by Region (2027-2032) Table 18. Global NK Cells Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (g) Table 19. Global NK Cells Sales by Region (2021-2026) & (g) Table 20. Global NK Cells Sales by Region (2027-2032) & (g) Table 21. Global NK Cells Sales Market Share by Region (2021-2026) Table 22. Global NK Cells Sales Market Share by Region (2027-2032) Table 23. Global NK Cells Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global NK Cells Revenue Market Share by Manufacturers (2021-2026) Table 25. Global NK Cells Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global NK Cells Sales Market Share by Manufacturers (2021-2026) Table 27. Global NK Cells Sales Price (US$/g) of Manufacturers (2021-2026) Table 28. Global NK Cells Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global NK Cells Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global NK Cells Manufacturers, Product Type & Application Table 31. Global NK Cells Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global NK Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global NK Cells Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global NK Cells Revenue by Type (2021-2026) & (US$ Million) Table 36. Global NK Cells Revenue by Type (2027-2032) & (US$ Million) Table 37. Global NK Cells Revenue Market Share by Type (2021-2026) Table 38. Global NK Cells Revenue Market Share by Type (2027-2032) Table 39. Global NK Cells Sales by Type 2021 VS 2025 VS 2032 (g) Table 40. Global NK Cells Sales by Type (2021-2026) & (g) Table 41. Global NK Cells Sales by Type (2027-2032) & (g) Table 42. Global NK Cells Sales Market Share by Type (2021-2026) Table 43. Global NK Cells Sales Market Share by Type (2027-2032) Table 44. Global NK Cells Price by Type (2021-2026) & (US$/g) Table 45. Global NK Cells Price by Type (2027-2032) & (US$/g) Table 46. Global NK Cells Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global NK Cells Revenue by Application (2021-2026) & (US$ Million) Table 48. Global NK Cells Revenue by Application (2027-2032) & (US$ Million) Table 49. Global NK Cells Revenue Market Share by Application (2021-2026) Table 50. Global NK Cells Revenue Market Share by Application (2027-2032) Table 51. Global NK Cells Sales by Application 2021 VS 2025 VS 2032 (g) Table 52. Global NK Cells Sales by Application (2021-2026) & (g) Table 53. Global NK Cells Sales by Application (2027-2032) & (g) Table 54. Global NK Cells Sales Market Share by Application (2021-2026) Table 55. Global NK Cells Sales Market Share by Application (2027-2032) Table 56. Global NK Cells Price by Application (2021-2026) & (US$/g) Table 57. Global NK Cells Price by Application (2027-2032) & (US$/g) Table 58. Affimed NV Company Information Table 59. Affimed NV Business Overview Table 60. Affimed NV NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. Affimed NV NK Cells Product Portfolio Table 62. Affimed NV Recent Development Table 63. Altor BioScience Company Information Table 64. Altor BioScience Business Overview Table 65. Altor BioScience NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Altor BioScience NK Cells Product Portfolio Table 67. Altor BioScience Recent Development Table 68. Chipscreen Biosciences Company Information Table 69. Chipscreen Biosciences Business Overview Table 70. Chipscreen Biosciences NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Chipscreen Biosciences NK Cells Product Portfolio Table 72. Chipscreen Biosciences Recent Development Table 73. Fortress Biotech Company Information Table 74. Fortress Biotech Business Overview Table 75. Fortress Biotech NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Fortress Biotech NK Cells Product Portfolio Table 77. Fortress Biotech Recent Development Table 78. Henry Ford Health Services Company Information Table 79. Henry Ford Health Services Business Overview Table 80. Henry Ford Health Services NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Henry Ford Health Services NK Cells Product Portfolio Table 82. Henry Ford Health Services Recent Development Table 83. Innate Pharma Company Information Table 84. Innate Pharma Business Overview Table 85. Innate Pharma NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Innate Pharma NK Cells Product Portfolio Table 87. Innate Pharma Recent Development Table 88. NantKwest Company Information Table 89. NantKwest Business Overview Table 90. NantKwest NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. NantKwest NK Cells Product Portfolio Table 92. NantKwest Recent Development Table 93. NKT Company Information Table 94. NKT Business Overview Table 95. NKT NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. NKT NK Cells Product Portfolio Table 97. NKT Recent Development Table 98. Sorrento Therapeutics Company Information Table 99. Sorrento Therapeutics Business Overview Table 100. Sorrento Therapeutics NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Sorrento Therapeutics NK Cells Product Portfolio Table 102. Sorrento Therapeutics Recent Development Table 103. Bristol-Myers Squibb Company Information Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb NK Cells Product Portfolio Table 107. Bristol-Myers Squibb Recent Development Table 108. Takeda Company Information Table 109. Takeda Business Overview Table 110. Takeda NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Takeda NK Cells Product Portfolio Table 112. Takeda Recent Development Table 113. North America NK Cells Revenue by Type (2021-2026) & (US$ Million) Table 114. North America NK Cells Revenue by Type (2027-2032) & (US$ Million) Table 115. North America NK Cells Sales by Type (2021-2026) & (g) Table 116. North America NK Cells Sales by Type (2027-2032) & (g) Table 117. North America NK Cells Sales Price by Type (2021-2026) & (US$/g) Table 118. North America NK Cells Sales Price by Type (2027-2032) & (US$/g) Table 119. North America NK Cells Revenue by Application (2021-2026) & (US$ Million) Table 120. North America NK Cells Revenue by Application (2027-2032) & (US$ Million) Table 121. North America NK Cells Sales by Application (2021-2026) & (g) Table 122. North America NK Cells Sales by Application (2027-2032) & (g) Table 123. North America NK Cells Sales Price by Application (2021-2026) & (US$/g) Table 124. North America NK Cells Sales Price by Application (2027-2032) & (US$/g) Table 125. North America NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America NK Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America NK Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America NK Cells Sales by Country (2021 VS 2025 VS 2032) & (g) Table 129. North America NK Cells Sales by Country (2021-2026) & (g) Table 130. North America NK Cells Sales by Country (2027-2032) & (g) Table 131. North America NK Cells Sales Price by Country (2021-2026) & (US$/g) Table 132. North America NK Cells Sales Price by Country (2027-2032) & (US$/g) Table 133. United States NK Cells Revenue (2021-2032) & (US$ Million) Table 134. Canada NK Cells Revenue (2021-2032) & (US$ Million) Table 135. Mexico NK Cells Revenue (2021-2032) & (US$ Million) Table 136. Europe NK Cells Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe NK Cells Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe NK Cells Sales by Type (2021-2026) & (g) Table 139. Europe NK Cells Sales by Type (2027-2032) & (g) Table 140. Europe NK Cells Sales Price by Type (2021-2026) & (US$/g) Table 141. Europe NK Cells Sales Price by Type (2027-2032) & (US$/g) Table 142. Europe NK Cells Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe NK Cells Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe NK Cells Sales by Application (2021-2026) & (g) Table 145. Europe NK Cells Sales by Application (2027-2032) & (g) Table 146. Europe NK Cells Sales Price by Application (2021-2026) & (US$/g) Table 147. Europe NK Cells Sales Price by Application (2027-2032) & (US$/g) Table 148. Europe NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe NK Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe NK Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe NK Cells Sales by Country (2021 VS 2025 VS 2032) & (g) Table 152. Europe NK Cells Sales by Country (2021-2026) & (g) Table 153. Europe NK Cells Sales by Country (2027-2032) & (g) Table 154. Europe NK Cells Sales Price by Country (2021-2026) & (US$/g) Table 155. Europe NK Cells Sales Price by Country (2027-2032) & (US$/g) Table 156. Germany NK Cells Revenue (2021-2032) & (US$ Million) Table 157. France NK Cells Revenue (2021-2032) & (US$ Million) Table 158. U.K. NK Cells Revenue (2021-2032) & (US$ Million) Table 159. Italy NK Cells Revenue (2021-2032) & (US$ Million) Table 160. Russia NK Cells Revenue (2021-2032) & (US$ Million) Table 161. Spain NK Cells Revenue (2021-2032) & (US$ Million) Table 162. Netherlands NK Cells Revenue (2021-2032) & (US$ Million) Table 163. Switzerland NK Cells Revenue (2021-2032) & (US$ Million) Table 164. Sweden NK Cells Revenue (2021-2032) & (US$ Million) Table 165. Poland NK Cells Revenue (2021-2032) & (US$ Million) Table 166. China NK Cells Revenue by Type (2021-2026) & (US$ Million) Table 167. China NK Cells Revenue by Type (2027-2032) & (US$ Million) Table 168. China NK Cells Sales by Type (2021-2026) & (g) Table 169. China NK Cells Sales by Type (2027-2032) & (g) Table 170. China NK Cells Sales Price by Type (2021-2026) & (US$/g) Table 171. China NK Cells Sales Price by Type (2027-2032) & (US$/g) Table 172. China NK Cells Revenue by Application (2021-2026) & (US$ Million) Table 173. China NK Cells Revenue by Application (2027-2032) & (US$ Million) Table 174. China NK Cells Sales by Application (2021-2026) & (g) Table 175. China NK Cells Sales by Application (2027-2032) & (g) Table 176. China NK Cells Sales Price by Application (2021-2026) & (US$/g) Table 177. China NK Cells Sales Price by Application (2027-2032) & (US$/g) Table 178. Asia NK Cells Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia NK Cells Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia NK Cells Sales by Type (2021-2026) & (g) Table 181. Asia NK Cells Sales by Type (2027-2032) & (g) Table 182. Asia NK Cells Sales Price by Type (2021-2026) & (US$/g) Table 183. Asia NK Cells Sales Price by Type (2027-2032) & (US$/g) Table 184. Asia NK Cells Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia NK Cells Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia NK Cells Sales by Application (2021-2026) & (g) Table 187. Asia NK Cells Sales by Application (2027-2032) & (g) Table 188. Asia NK Cells Sales Price by Application (2021-2026) & (US$/g) Table 189. Asia NK Cells Sales Price by Application (2027-2032) & (US$/g) Table 190. Asia NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia NK Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia NK Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia NK Cells Sales by Country (2021 VS 2025 VS 2032) & (g) Table 194. Asia NK Cells Sales by Country (2021-2026) & (g) Table 195. Asia NK Cells Sales by Country (2027-2032) & (g) Table 196. Asia NK Cells Sales Price by Country (2021-2026) & (US$/g) Table 197. Asia NK Cells Sales Price by Country (2027-2032) & (US$/g) Table 198. Japan NK Cells Revenue (2021-2032) & (US$ Million) Table 199. South Korea NK Cells Revenue (2021-2032) & (US$ Million) Table 200. India NK Cells Revenue (2021-2032) & (US$ Million) Table 201. Australia NK Cells Revenue (2021-2032) & (US$ Million) Table 202. Taiwan NK Cells Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia NK Cells Revenue (2021-2032) & (US$ Million) Table 204. SAMEA NK Cells Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA NK Cells Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA NK Cells Sales by Type (2021-2026) & (g) Table 207. SAMEA NK Cells Sales by Type (2027-2032) & (g) Table 208. SAMEA NK Cells Sales Price by Type (2021-2026) & (US$/g) Table 209. SAMEA NK Cells Sales Price by Type (2027-2032) & (US$/g) Table 210. SAMEA NK Cells Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA NK Cells Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA NK Cells Sales by Application (2021-2026) & (g) Table 213. SAMEA NK Cells Sales by Application (2027-2032) & (g) Table 214. SAMEA NK Cells Sales Price by Application (2021-2026) & (US$/g) Table 215. SAMEA NK Cells Sales Price by Application (2027-2032) & (US$/g) Table 216. SAMEA NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA NK Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA NK Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA NK Cells Sales by Country (2021 VS 2025 VS 2032) & (g) Table 220. SAMEA NK Cells Sales by Country (2021-2026) & (g) Table 221. SAMEA NK Cells Sales by Country (2027-2032) & (g) Table 222. SAMEA NK Cells Sales Price by Country (2021-2026) & (US$/g) Table 223. SAMEA NK Cells Sales Price by Country (2027-2032) & (US$/g) Table 224. Brazil NK Cells Revenue (2021-2032) & (US$ Million) Table 225. Argentina NK Cells Revenue (2021-2032) & (US$ Million) Table 226. Chile NK Cells Revenue (2021-2032) & (US$ Million) Table 227. Colombia NK Cells Revenue (2021-2032) & (US$ Million) Table 228. Peru NK Cells Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia NK Cells Revenue (2021-2032) & (US$ Million) Table 230. Israel NK Cells Revenue (2021-2032) & (US$ Million) Table 231. UAE NK Cells Revenue (2021-2032) & (US$ Million) Table 232. Turkey NK Cells Revenue (2021-2032) & (US$ Million) Table 233. Iran NK Cells Revenue (2021-2032) & (US$ Million) Table 234. Egypt NK Cells Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. NK Cells Distributors List Table 238. NK Cells Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. NK Cells Image Figure 2. Global NK Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK Cells Market Size Share 2021 VS 2025 VS 2032 Figure 4. Mogamulizumab Image Figure 5. Lorvotuzumab Mertansine Image Figure 6. Others Image Figure 7. Global NK Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global NK Cells Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cancer Image Figure 10. Cardiovascular Diseases Image Figure 11. Others Image Figure 12. Global NK Cells Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global NK Cells Revenue (2021-2032) & (US$ Million) Figure 14. Global NK Cells Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global NK Cells Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global NK Cells Revenue Market Share by Region (2021-2032) Figure 17. Global NK Cells Sales (2021-2032) & (g) Figure 18. Global NK Cells Sales by Region: 2021 VS 2025 VS 2032 (g) Figure 19. Global NK Cells Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico NK Cells Sales YoY (2021-2032) & (g) Figure 21. Europe NK Cells Sales YoY (2021-2032) & (g) Figure 22. China NK Cells Sales YoY (2021-2032) & (g) Figure 23. Asia (Excluding China) NK Cells Sales YoY (2021-2032) & (g) Figure 24. South America, Middle East and Africa NK Cells Sales YoY (2021-2032) & (g) Figure 25. Global NK Cells Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global NK Cells Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global NK Cells Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global NK Cells Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global NK Cells Revenue Market Share by Type (2021-2032) Figure 31. Global NK Cells Sales by Type (2021 VS 2025 VS 2032) & (g) Figure 32. Global NK Cells Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global NK Cells Sales Market Share by Type (2021-2032) Figure 34. Global NK Cells Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global NK Cells Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global NK Cells Revenue Market Share by Application (2021-2032) Figure 37. Global NK Cells Sales by Application (2021 VS 2025 VS 2032) & (g) Figure 38. Global NK Cells Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global NK Cells Sales Market Share by Application (2021-2032) Figure 40. North America NK Cells Revenue Share by Type (2021-2032) Figure 41. North America NK Cells Sales Share by Type (2021-2032) Figure 42. North America NK Cells Revenue Share by Application (2021-2032) Figure 43. North America NK Cells Sales Share by Application (2021-2032) Figure 44. North America NK Cells Revenue Share by Country (2021-2032) Figure 45. North America NK Cells Sales Share by Country (2021-2032) Figure 46. Europe NK Cells Revenue Share by Type (2021-2032) Figure 47. Europe NK Cells Sales Share by Type (2021-2032) Figure 48. Europe NK Cells Revenue Share by Application (2021-2032) Figure 49. Europe NK Cells Sales Share by Application (2021-2032) Figure 50. Europe NK Cells Revenue Share by Country (2021-2032) Figure 51. Europe NK Cells Sales Share by Country (2021-2032) Figure 52. China NK Cells Revenue Share by Type (2021-2032) Figure 53. China NK Cells Sales Share by Type (2021-2032) Figure 54. China NK Cells Revenue Share by Application (2021-2032) Figure 55. China NK Cells Sales Share by Application (2021-2032) Figure 56. Asia NK Cells Revenue Share by Type (2021-2032) Figure 57. Asia NK Cells Sales Share by Type (2021-2032) Figure 58. Asia NK Cells Revenue Share by Application (2021-2032) Figure 59. Asia NK Cells Sales Share by Application (2021-2032) Figure 60. Asia NK Cells Revenue Share by Country (2021-2032) Figure 61. Asia NK Cells Sales Share by Country (2021-2032) Figure 62. SAMEA NK Cells Revenue Share by Type (2021-2032) Figure 63. SAMEA NK Cells Sales Share by Type (2021-2032) Figure 64. SAMEA NK Cells Revenue Share by Application (2021-2032) Figure 65. SAMEA NK Cells Sales Share by Application (2021-2032) Figure 66. SAMEA NK Cells Revenue Share by Country (2021-2032) Figure 67. SAMEA NK Cells Sales Share by Country (2021-2032) Figure 68. NK Cells Value Chain Figure 69. Manufacturing Cost Structure Figure 70. NK Cells Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Applications
  • Cancer
  • Cardiovascular Diseases
  • Others
Companies covered
  • Affimed NV
  • Altor BioScience
  • Chipscreen Biosciences
  • Fortress Biotech
  • Henry Ford Health Services
  • Innate Pharma
  • NantKwest
  • NKT
  • Sorrento Therapeutics
  • Bristol-Myers Squibb
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 NK Cells Market by Type
  3. 1.2.1 Global NK Cells Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Mogamulizumab
  5. 1.2.3 Lorvotuzumab Mertansine
  6. 1.2.4 Others
  7. 1.3 NK Cells Market by Application
  8. 1.3.1 Global NK Cells Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Cardiovascular Diseases
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 NK Cells Market Dynamics
  1. 2.1 NK Cells Industry Trends
  2. 2.2 NK Cells Industry Drivers
  3. 2.3 NK Cells Industry Opportunities and Challenges
  4. 2.4 NK Cells Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global NK Cells Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global NK Cells Revenue by Region
  3. 3.2.1 Global NK Cells Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global NK Cells Revenue by Region (2021-2026)
  5. 3.2.3 Global NK Cells Revenue by Region (2027-2032)
  6. 3.2.4 Global NK Cells Revenue Market Share by Region (2021-2032)
  7. 3.3 Global NK Cells Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global NK Cells Sales by Region
  9. 3.4.1 Global NK Cells Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global NK Cells Sales by Region (2021-2026)
  11. 3.4.3 Global NK Cells Sales by Region (2027-2032)
  12. 3.4.4 Global NK Cells Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global NK Cells Revenue by Manufacturers
  2. 4.1.1 Global NK Cells Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global NK Cells Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global NK Cells Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global NK Cells Sales by Manufacturers
  6. 4.2.1 Global NK Cells Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global NK Cells Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global NK Cells Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global NK Cells Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global NK Cells Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global NK Cells Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global NK Cells Manufacturers, Product Type & Application
  13. 4.7 Global NK Cells Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global NK Cells Market CR5 and HHI
  16. 4.8.2 2025 NK Cells Tier 1, Tier 2, and Tier 3
5 NK Cells Market by Type
  1. 5.1 Global NK Cells Revenue by Type
  2. 5.1.1 Global NK Cells Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global NK Cells Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global NK Cells Revenue Market Share by Type (2021-2032)
  5. 5.2 Global NK Cells Sales by Type
  6. 5.2.1 Global NK Cells Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NK Cells Sales by Type (2021-2032) & (g)
  8. 5.2.3 Global NK Cells Sales Market Share by Type (2021-2032)
  9. 5.3 Global NK Cells Price by Type
6 NK Cells Market by Application
  1. 6.1 Global NK Cells Revenue by Application
  2. 6.1.1 Global NK Cells Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global NK Cells Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global NK Cells Revenue Market Share by Application (2021-2032)
  5. 6.2 Global NK Cells Sales by Application
  6. 6.2.1 Global NK Cells Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global NK Cells Sales by Application (2021-2032) & (g)
  8. 6.2.3 Global NK Cells Sales Market Share by Application (2021-2032)
  9. 6.3 Global NK Cells Price by Application
7 Company Profiles
  1. 7.1 Affimed NV
  2. 7.1.1 Affimed NV Company Information
  3. 7.1.2 Affimed NV Business Overview
  4. 7.1.3 Affimed NV NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Affimed NV NK Cells Product Portfolio
  6. 7.1.5 Affimed NV Recent Developments
  7. 7.2 Altor BioScience
  8. 7.2.1 Altor BioScience Company Information
  9. 7.2.2 Altor BioScience Business Overview
  10. 7.2.3 Altor BioScience NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Altor BioScience NK Cells Product Portfolio
  12. 7.2.5 Altor BioScience Recent Developments
  13. 7.3 Chipscreen Biosciences
  14. 7.3.1 Chipscreen Biosciences Company Information
  15. 7.3.2 Chipscreen Biosciences Business Overview
  16. 7.3.3 Chipscreen Biosciences NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chipscreen Biosciences NK Cells Product Portfolio
  18. 7.3.5 Chipscreen Biosciences Recent Developments
  19. 7.4 Fortress Biotech
  20. 7.4.1 Fortress Biotech Company Information
  21. 7.4.2 Fortress Biotech Business Overview
  22. 7.4.3 Fortress Biotech NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fortress Biotech NK Cells Product Portfolio
  24. 7.4.5 Fortress Biotech Recent Developments
  25. 7.5 Henry Ford Health Services
  26. 7.5.1 Henry Ford Health Services Company Information
  27. 7.5.2 Henry Ford Health Services Business Overview
  28. 7.5.3 Henry Ford Health Services NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Henry Ford Health Services NK Cells Product Portfolio
  30. 7.5.5 Henry Ford Health Services Recent Developments
  31. 7.6 Innate Pharma
  32. 7.6.1 Innate Pharma Company Information
  33. 7.6.2 Innate Pharma Business Overview
  34. 7.6.3 Innate Pharma NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Innate Pharma NK Cells Product Portfolio
  36. 7.6.5 Innate Pharma Recent Developments
  37. 7.7 NantKwest
  38. 7.7.1 NantKwest Company Information
  39. 7.7.2 NantKwest Business Overview
  40. 7.7.3 NantKwest NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 NantKwest NK Cells Product Portfolio
  42. 7.7.5 NantKwest Recent Developments
  43. 7.8 NKT
  44. 7.8.1 NKT Company Information
  45. 7.8.2 NKT Business Overview
  46. 7.8.3 NKT NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 NKT NK Cells Product Portfolio
  48. 7.8.5 NKT Recent Developments
  49. 7.9 Sorrento Therapeutics
  50. 7.9.1 Sorrento Therapeutics Company Information
  51. 7.9.2 Sorrento Therapeutics Business Overview
  52. 7.9.3 Sorrento Therapeutics NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sorrento Therapeutics NK Cells Product Portfolio
  54. 7.9.5 Sorrento Therapeutics Recent Developments
  55. 7.10 Bristol-Myers Squibb
  56. 7.10.1 Bristol-Myers Squibb Company Information
  57. 7.10.2 Bristol-Myers Squibb Business Overview
  58. 7.10.3 Bristol-Myers Squibb NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bristol-Myers Squibb NK Cells Product Portfolio
  60. 7.10.5 Bristol-Myers Squibb Recent Developments
  61. 7.11 Takeda
  62. 7.11.1 Takeda Company Information
  63. 7.11.2 Takeda Business Overview
  64. 7.11.3 Takeda NK Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Takeda NK Cells Product Portfolio
  66. 7.11.5 Takeda Recent Developments
8 North America
  1. 8.1 North America NK Cells Market Size by Type
  2. 8.1.1 North America NK Cells Revenue by Type (2021-2032)
  3. 8.1.2 North America NK Cells Sales by Type (2021-2032)
  4. 8.1.3 North America NK Cells Price by Type (2021-2032)
  5. 8.2 North America NK Cells Market Size by Application
  6. 8.2.1 North America NK Cells Revenue by Application (2021-2032)
  7. 8.2.2 North America NK Cells Sales by Application (2021-2032)
  8. 8.2.3 North America NK Cells Price by Application (2021-2032)
  9. 8.3 North America NK Cells Market Size by Country
  10. 8.3.1 North America NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America NK Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America NK Cells Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe NK Cells Market Size by Type
  2. 9.1.1 Europe NK Cells Revenue by Type (2021-2032)
  3. 9.1.2 Europe NK Cells Sales by Type (2021-2032)
  4. 9.1.3 Europe NK Cells Price by Type (2021-2032)
  5. 9.2 Europe NK Cells Market Size by Application
  6. 9.2.1 Europe NK Cells Revenue by Application (2021-2032)
  7. 9.2.2 Europe NK Cells Sales by Application (2021-2032)
  8. 9.2.3 Europe NK Cells Price by Application (2021-2032)
  9. 9.3 Europe NK Cells Market Size by Country
  10. 9.3.1 Europe NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe NK Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe NK Cells Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China NK Cells Market Size by Type
  2. 10.1.1 China NK Cells Revenue by Type (2021-2032)
  3. 10.1.2 China NK Cells Sales by Type (2021-2032)
  4. 10.1.3 China NK Cells Price by Type (2021-2032)
  5. 10.2 China NK Cells Market Size by Application
  6. 10.2.1 China NK Cells Revenue by Application (2021-2032)
  7. 10.2.2 China NK Cells Sales by Application (2021-2032)
  8. 10.2.3 China NK Cells Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia NK Cells Market Size by Type
  2. 11.1.1 Asia NK Cells Revenue by Type (2021-2032)
  3. 11.1.2 Asia NK Cells Sales by Type (2021-2032)
  4. 11.1.3 Asia NK Cells Price by Type (2021-2032)
  5. 11.2 Asia NK Cells Market Size by Application
  6. 11.2.1 Asia NK Cells Revenue by Application (2021-2032)
  7. 11.2.2 Asia NK Cells Sales by Application (2021-2032)
  8. 11.2.3 Asia NK Cells Price by Application (2021-2032)
  9. 11.3 Asia NK Cells Market Size by Country
  10. 11.3.1 Asia NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia NK Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia NK Cells Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA NK Cells Market Size by Type
  2. 12.1.1 SAMEA NK Cells Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA NK Cells Sales by Type (2021-2032)
  4. 12.1.3 SAMEA NK Cells Price by Type (2021-2032)
  5. 12.2 SAMEA NK Cells Market Size by Application
  6. 12.2.1 SAMEA NK Cells Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA NK Cells Sales by Application (2021-2032)
  8. 12.2.3 SAMEA NK Cells Price by Application (2021-2032)
  9. 12.3 SAMEA NK Cells Market Size by Country
  10. 12.3.1 SAMEA NK Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA NK Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA NK Cells Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 NK Cells Value Chain Analysis
  2. 13.1.1 NK Cells Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 NK Cells Production Mode & Process
  6. 13.2 NK Cells Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 NK Cells Distributors
  9. 13.2.3 NK Cells Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst